Melissa Shimshock
Family · Sandusky, MINPI 1215432927
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for family clinicians in MI, where the typical reported total is $349.
Across 26 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$54
- Amgen$50
- Teva Pharmaceuticals USA, Inc.$37
- Amarin Pharma, Inc.$35
- Biohaven Pharmaceuticals, Inc.$32
- Johnson & Johnson$30
- plus $183 from 11 others
What the payments were for
- Food & beverage$421100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $54 |
| Amgen | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Boehringer Ingelheim | 1 | $22 |
| Mylan Specialty L.p. | 1 | $18 |
| Indivior Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Pfizer | 1 | $14 |
| Medtronic | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| QOL Medical, LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$421 in reported general payments places this provider in the 50th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 15 | $100 |
| Cephalexin | 25 | $97 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $45 |
| Cyclobenzaprine Hcl | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other family in Sandusky
- Lori BjornsonSandusky$18K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.